Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Kite, Pfizer enter clinical trial collaboration

Executive Summary

Gilead Sciences Inc.'s Kite Pharma Inc. is teaming up with Pfizer Inc. in a trial collaboration to study the safety and efficacy of Kite's Yescarta (axicabtagene ciloleucel) in combination with Pfizer's utomilumab (PF05082566) for treating patients with refractory large B-cell lymphoma.
Deal Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Alliance
    • Trial Collaborations

Related Companies

UsernamePublicRestriction

Register